Skip to main content
Screener/Healthcare/Biotechnology

COGT — Cogent Biosciences, Inc.

NASDAQ
$42.46+0.66 (+1.58%)
Mid CapUnder $50HealthcareLow Beta
$10.38
$43.73
$41.70
$42.92
EPS (TTM)$-3.08
P/E Ratio-7.47
Dividend Yield—
Market Cap$7.32B
Volume1.26M
Prev Close$41.80
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$97.4M$-0.60——
Q4 '25$0-$102.5M$-1.13——
Q3 '25$0-$80.9M$-0.71——
Q2 '25$0-$73.5M$-0.64——
Q1 '25$0-$72.0M$-0.52——
Q4 '24$0-$67.9M$-0.61——
Q3 '24$0-$70.6M$-0.64——
Q2 '24$0-$59.0M$-0.59——
Get Your Daily Market Recap
COGT Stock Price, Chart & Analysis